NCT07279363Not yet recruiting
Deaf CBT-TS to Reduce Suicide Risk
Cognitive Behavioral Therapy for Treatment-Seeking to Improve Treatment Engagement and Reduce Suicide Risk Among Deaf Individuals
Source: ClinicalTrials.gov · Last updated 4 Nov 2026
Brief summary (registry, in English)
The goal of this clinical trial is to learn if a short, Zoom-based intervention, Cognitive Behavioral Therapy for Treatment-Seeking for Deaf Individuals (Deaf CBT-TS) can change beliefs about mental health treatment and increase treatment-seeking behaviors in Deaf adults with untreated mental health or alcohol use problems. It will also see if Deaf CBT-TS may reduce suicide risk and explore factors that may increase the effectiveness of Deaf CBT-TS. The main questions it aims to answer are: * Does Deaf CBT-TS increase positive beliefs about treatment and increase treatment-seeking behaviors? * Does Deaf CBT-TS increase hope and reduce mental health symptoms, suicide ideation, and alcohol use? * Is Deaf CBT-TS more effective for individuals with less cultural stress compared to those with high levels of cultural stress? * Is Deaf CBT-TS more effective for Deaf individuals in residential areas with more Deaf resources than those with less Deaf resources? Researchers will compare individuals who complete Deaf CBT-TS to those on a waitlist to see if Deaf CBT-TS works to increase positive beliefs about treatment and treatment-seeking behaviors. Participants will: * Complete a baseline assessment including demographic information, measures of hope, general mental health and functioning, alcohol use, suicide ideation, cultural stress, and beliefs about treatment. * Receive Deaf CBT-TS (2 sessions) or be placed on a waitlist with the option of receiving Deaf CBT-Ts after 4 months * Complete two follow-up assessments in 2 and 4 months.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 110 (estimated)
- First submitted
- 8 Dec 2025
- Start date
- Dec 2026
- Primary completion date
- May 2029
- Lead sponsor
- University of Rochester
- Diseases
- Depression
- NCT number
- NCT07279363
What you commit to
- Study type: Interventional
- Planned participants: 110
- From Dec 2026 to the primary completion date, May 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- current psychiatric impairment necessitating emergency services or inpatient admission (i.e., imminent danger of harm to self or others)
Other
- unable to communicate with the researcher in American Sign Language
- current alcohol withdrawal necessitating medical evaluation
- unable to comprehend the nature of the study
Who the study is looking for
- adult (aged 18 years or older)
- Self-identify as Deaf or hard of hearing (any degree of hearing loss)
- Primary method of communication is American Sign Language
- Positive screen for one or more mental health disorders including depression (PHQ-9 \> 10), anxiety (GAD-7 \> 10), posttraumatic stress disorder (PCL-5 \> 31), insomnia (ISI \> 15), or alcohol use disorder (AUDIT \> 16)
- No current professional mental health or alcohol specialty treatment (e.g., counseling, psychiatric services) per standardized self-report
- Access to video chat technology with internet and webcam.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Rochester Medical Center Coordinator of this site? Confirm its status | Rochester | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.